Clinical Trial Update: Comparison Between Home Macular Perimeter and Optical Coherence Tomography (OCT) Visual Field Defects in Patients With Choroidal Neovascularization (CNV)

View source ↗

Summary

The clinical trial comparing a home macular perimeter with OCT for assessing visual field defects in choroidal neovascularization has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization

Snippet

Sponsor: Notal Vision Ltd. | Conditions: Age Related Macular Degeneration, Choroidal Neovascularization | Status: WITHDRAWN